Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5FU-Irinotecan-Cisplatin in Metastatic Esophageal Cancer
NCT00075738Phase 2Unknown
- Sponsor
- GERCOR
- Start
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan in esophageal cancer, sponsored by GERCOR. Status: unknown.
02
Drugs
irinotecan
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00075738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00075738.